Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
Objective. Patients with anti-Jo-1 antibodies (Abs) and anti–melanoma differentiation-associated protein 5 (MDA5) Abs are at a higher risk of interstitial lung disease (ILD) and have a mortality rate higher than that of patients with anti-Jo-1 Abs. This study investigated differences in the clinical...
Saved in:
| Main Authors: | Chao-Han Liu, Chew-Teng Kor, Ming-Hui Hung, Kai-Hung Hsiao, Yen-Huang Cheng, Ya-Chih Tien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2023/2988422 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yun Wu, et al.
Published: (2025-08-01) -
Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis
by: Chao Sun, et al.
Published: (2025-07-01) -
Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
by: Moises Labrador-Horrillo, et al.
Published: (2014-01-01) -
Anti-MDA-5 dermatomyositis with tumid lupus-like lesions
by: Kristiana Marie Jordan, BA, et al.
Published: (2025-06-01) -
Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis
by: Yahui Yang, et al.
Published: (2025-07-01)